| Announce Date | 10/27/2025 |
| EPS Normalized Actual | $2.62 (Beat by $0.31) |
| EPS GAAP Actual | $2.62 (Beat by $0.31) |
| Revenue Actual | $0.543736B |
| Revenue Surprise | Beat by $543.736M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.5 | 2.5 | 0.543736B | 7.35% | 543.74M |
| FQ2 2025 (Jun 2025) | 1.92 | 1.92 | 0.540959B | 7.03% | 540.96M |
| FQ1 2025 (Mar 2025) | 1.88 | 1.88 | 0.507692B | 7.68% | 507.69M |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 0.533772B | 7.4% | 533.77M |
| FQ3 2024 (Sep 2024) | 1.81 | 1.81 | 0.503773B | 4.61% | 503.77M |
| FQ2 2024 (Jun 2024) | 1.53 | 1.53 | 0.502951B | 7.2% | 502.95M |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 0.468701B | 100% | 468.7M |
| FQ4 2023 (Dec 2023) | 1.61 | 1.61 | 0.494296B | -1.41% | 494.3M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.835 | -- | 2.80563 | 2.8616 | 2 |
| FQ3 2027 (Sep 2027) | 2.675 | -- | 2.64728 | 2.70009 | 2 |
| FQ2 2027 (Jun 2027) | 2.53 | -- | 2.50379 | 2.55373 | 2 |
| FQ1 2027 (Mar 2027) | 2.395 | -- | 2.37019 | 2.41747 | 2 |
| FQ4 2026 (Dec 2026) | 2.51833 | -- | 2.49224 | 2.54195 | 2 |
| FQ3 2026 (Sep 2026) | 2.54714 | 1.85 | 2.52075 | 2.57103 | 2 |
| FQ2 2026 (Jun 2026) | 1.95 | 1.54 | 1.89888 | 1.98001 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.63B | -- | 0.62B | 0.63B | 3 |
| FQ3 2027 (Sep 2027) | 0.6B | -- | 0.59B | 0.6B | 3 |
| FQ2 2027 (Jun 2027) | 0.59B | -- | 0.59B | 0.6B | 3 |
| FQ1 2027 (Mar 2027) | 0.56B | -- | 0.55B | 0.56B | 3 |
| FQ4 2026 (Dec 2026) | 0.6B | -- | 0.6B | 0.6B | 3 |
| FQ3 2026 (Sep 2026) | 0.57B | 4.46 | 0.56B | 0.57B | 3 |
| FQ2 2026 (Jun 2026) | 0.54B | 0.46 | 0.53B | 0.55B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.5 | 2.5 | 100% | |
| FQ2 2025 (Jun 2025) | 1.92 | 1.92 | 100% | |
| FQ1 2025 (Mar 2025) | 1.88 | 1.88 | 100% | |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 100% | |
| FQ3 2024 (Sep 2024) | 1.81 | 1.81 | 100% | |
| FQ2 2024 (Jun 2024) | 1.53 | 1.53 | 100% | |
| FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 100% | |
| FQ4 2023 (Dec 2023) | 1.61 | 1.61 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.54B | $543.74M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.54B | $540.96M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.51B | $507.69M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.53B | $533.77M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.5B | $503.77M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.5B | $502.95M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.47B | $468.7M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.49B | $494.3M | 100% |